Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.085 USD | -0.31% | +1.51% | -0.49% |
06-20 | JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating | MT |
06-11 | Iovance Biotherapeutics, Inc. Elects Frederick G. Vogt as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.49% | 2.27B | |
-38.50% | 8.15B | |
+8.06% | 3.6B | |
-26.02% | 1.9B | |
-17.63% | 1.72B | |
+5.88% | 922M | |
+20.08% | 731M | |
-12.45% | 679M | |
-29.90% | 503M | |
-1.89% | 288M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating